Fig. 2: Therapeutic scheme for GH-RH and LH-RH analogs in blocking BPH development.
From: A 50-year journey in the development of treatment for benign prostatic hyperplasia
The integration of GH-RH and LH-RH analogs into clinical practice could revolutionize BPH management, providing an effective, non-surgical alternative for patients with progressive disease.
